Top Markets
#1 TENDIES TENDIES +60.89%
#2 Threshold Network Threshold Network +48.72%
#3 Cash Cat Cash Cat +21.98%
#4 OSK OSK +16.53%
#5 Kinetiq Kinetiq +16.42%
#6 Maple Finance Maple Finance +13.30%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 Magma Finance Magma Finance +12.46%
#9 Falcon Finance Falcon Finance +11.62%
#10 Kite Kite +11.22%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Rank in Stocks #17292
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Share Price
$1.35
Last synced: 2026-09-01
Market Cap
$249.21M
Change (1 day)
1.13%
Change (1 year)
-22.70%
Country
US
Trade Neumora Therapeutics, Inc. Common Stock (NMRA)

Category

Healthcare
Stock price history for Neumora Therapeutics, Inc. Common Stock (NMRA)
Highest end of day price: $1.36 on 2026-09-01

Lowest end of day price: $12.50 on 2023-09-01
Stock price history of Neumora Therapeutics, Inc. Common Stock from 2023 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 4.72%
2025 -81.20%
2024 -26.84%
2023 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $554.82 38.36%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.67%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.77 515.03%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $762.39 8.87%
CH